Showing 11 - 20 of 26
The economy is back at the centre of sociological analysis. This, of course, only means that it has recaptured the position it once held in the works of the sociological ‘founding fathers’, Simmel, Pareto, Weber, Marx, and Durkheim.The so-called ‘new economic sociology’ (NES) is a field...
Persistent link: https://www.econbiz.de/10011425477
Persistent link: https://www.econbiz.de/10011425496
Review of Naomi Klein's The Shock Doctrine: The rise of disaster capitalism
Persistent link: https://www.econbiz.de/10011425507
Review of Tim Congdon's Keynes, Keynesians, and Monetarism
Persistent link: https://www.econbiz.de/10011425518
The selective publication of clinical trials by the pharmaceutical industry and by academic investigators has long been a contentious area in medicine. Clinicians and scientists such as Iain Chalmers, one of the founders of the UK Cochrane Centre, have worked for over two decades to address the...
Persistent link: https://www.econbiz.de/10011425529
Persistent link: https://www.econbiz.de/10011425540
Review of Matthew Bishop and Michael Green's Philanthrocapitalism
Persistent link: https://www.econbiz.de/10011425549
Decisions about drugs by doctors, patients, and the public depend on a complex framework of industry regulation, professional and public guidance, and transparent publication of the research on which the regulatory framework depends. In the UK, there are two agencies with a national role in this...
Persistent link: https://www.econbiz.de/10011425560
Persistent link: https://www.econbiz.de/10011425569
Drawing on narrative interviews with psychiatrists and health analysts in Britain, the article provides an analysis of debates over the safety of SSRI antidepressants such as Prozac and Seroxat. The focus of the article is on what I describe, drawing on Foucault, Nietzsche, Niklas Luhmann and...
Persistent link: https://www.econbiz.de/10011425571